-
Mashup Score: 11Moving the dial on diagnostics | The Lancet Group - 1 month(s) ago
đ Nearly half of the global population lack access to basic diagnosticsâthe staggering reality highlighted by the Lancet Commission on diagnostics. In low-income and lower middle-income countries, this figure soars to 81% đ Three years since the Commission was launched, what progress has been made? Find out in this article —ïž
Source: www.linkedin.comCategories: General Medicine NewsTweet
-
Mashup Score: 0Nearly 70% of diagnostic errors occur during testing: ECRI - 10 month(s) ago
Discover the main drivers of diagnostic errors in 2023, including issues with medical tests, referral delays, and miscommunication, according to a new analysis.
Source: www.beckershospitalreview.comCategories: General Medicine News, General HCPsTweet
-
Mashup Score: 0Truvian Health raises $74M for automated blood diagnostics platform - 12 month(s) ago
The funding will be used to secure FDA clearance for its benchtop blood testing system for use in doctor’s offices, clinics and pharmacies.
Source: www.mobihealthnews.comCategories: General Medicine News, Future of MedicineTweet
-
Mashup Score: 0Gurugram-based healthcare startup Curelo raises funding worth $100k from IIM Ahmedabad - 2 year(s) ago
Gurugram-based healthcare startup Curelo raises funding worth $100k from IIM Ahmedabad
Source: www.biospectrumindia.comCategories: Healthcare Professionals, Latest HeadlinesTweet
-
Mashup Score: 0EU poised to mandate Illumina sell Grail liquid biopsy unit: FT - 2 year(s) ago
Regulators could order the divestment of the business as soon as next week to punish Illumina for defying their authority and âillegallyâ acquiring Grail.
Source: www.medtechdive.comCategories: Healthcare Professionals, Latest HeadlinesTweet
-
Mashup Score: 1Delfi launches lung cancer blood test based on DNA fragmentation - 2 year(s) ago
The test, FirstLook Lung, applies machine learning to whole-genome sequencing data to identify cfDNA patterns associated with lung cancer.
Source: www.medtechdive.comCategories: Healthcare Professionals, Latest HeadlinesTweet
-
Mashup Score: 0
Precede has used the money to develop a platform that reveals the activity of genes and pathways.
Source: www.medtechdive.comCategories: Healthcare Professionals, Latest HeadlinesTweet
-
Mashup Score: 0
At-home diagnostics startup Viome Life Sciences has launched a new test to help detect oral and throat cancers. | The test relies on Viomeâs proprietary RNA sequencing technology and AI to measure gene expression of the oral microbiome and human cells in each patientâs saliva, which are used to identify early biomarkers associated with oral and throat cancers.
Source: www.fiercehealthcare.comCategories: Healthcare Professionals, Latest HeadlinesTweet
-
Mashup Score: 0Invitae test for hereditary cancers gains FDA de novo nod - 2 year(s) ago
The genetic test analyzes DNA from a single blood sample to identify hundreds of variants in 47 genes associated with predispositions for a range of cancer types.Â
Source: www.medtechdive.comCategories: Healthcare Professionals, Latest HeadlinesTweet
-
Mashup Score: 0
The test developer will use the series B funding to complete a 10,000-subject clinical trial ahead of a planned launch in 2025.
Source: www.medtechdive.comCategories: Healthcare Professionals, Latest HeadlinesTweet
đ Nearly 1/2 of the global population lack access to basic #diagnosticsâthe staggering reality highlighted by a 2021 Lancet Commission. In low-income and lower middle-income countries, this figure soars to 81% đ Has any progress has been made? â€”ïž https://t.co/Z3pbTZ4vGs